The present invention relates to a method for profiling hepatocellular carcinoma comprising classifying survivin gene expression levels and/or survivin protein phosphorylation in HCC compared to a control. The present invention also includes treating HCC with survivin inhibitors, particularly in subjects with high survivin gene expression and/or survivin protein phosphorylation compared to normal liver tissue.
展开▼
